Connection
Robert Freedman to Neurocognitive Disorders
This is a "connection" page, showing publications Robert Freedman has written about Neurocognitive Disorders.
|
|
| |
Connection Strength |
|
 |
|
 |
| |
0.616 |
|
|
|
-
Gee KW, Olincy A, Kanner R, Johnson L, Hogenkamp D, Harris J, Tran M, Edmonds SA, Sauer W, Yoshimura R, Johnstone T, Freedman R. First in human trial of a type I positive allosteric modulator of alpha7-nicotinic acetylcholine receptors: Pharmacokinetics, safety, and evidence for neurocognitive effect of AVL-3288. J Psychopharmacol. 2017 04; 31(4):434-441.
Score: 0.497
-
Harris JG, Adler LE, Young DA, Cullum CM, Rilling LM, Cicerello A, Intemann PM, Freedman R. Neuropsychological dysfunction in parents of schizophrenics. Schizophr Res. 1996 Jul 05; 20(3):253-60.
Score: 0.119